Skip to content

Clinical trials

Completed Phase 3 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Status: Completed Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20028
200311
200425
200522
200616
20075
200810
20099
20104
20115
20123
20134
20143
20155
20166
20172
20181
20202
20211
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed162

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.16
AstraZeneca15
Organon and Co8
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Sumitomo Pharma America, Inc.8
GlaxoSmithKline7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
University Hospitals Cleveland Medical Center7
Intra-Cellular Therapies, Inc.6
Eli Lilly and Company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder162
Mania31
Psychotic Disorders12
Schizophrenia10
Major Depressive Disorder7
Affective Disorders, Psychotic5
Mood Disorders5
Depressive Disorder3
Mental Disorders3
Anxiety Disorders2

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.